Inhibition of SARS-CoV-2 Replication by Self-Assembled siRNA Nanoparticles Targeting Multiple Highly Conserved Viral...

Area of Science:

• Biotechnology
• Virology
• Nanomedicine

Background:

• The global COVID-19 pandemic, caused by SARS-CoV-2, highlights the urgent need for effective antiviral therapies.
• The high mutation rate of SARS-CoV-2 complicates the development of broad-spectrum vaccines and treatments.
• Small interfering RNA (siRNA) therapy offers a promising approach for sequence-specific gene silencing in antiviral applications.

Purpose of the Study:

• To develop and evaluate a novel self-assembled siRNA nanoparticle system for targeting highly conserved regions of SARS-CoV-2.
• To assess the efficacy of these siRNA nanoparticles in inhibiting SARS-CoV-2 replication compared to free siRNA.

Main Methods:

• Screening and evaluation of siRNA sequences targeting conserved SARS-CoV-2 regions based on thermodynamic stability, off-target effects, and toxicity.
• Design and self-assembly of siRNA into uniform and stable nanoparticles.
• In vitro assessment of nanoparticle cellular uptake via endocytic pathways and inhibition of SARS-CoV-2 replication.

Main Results:

• The developed siRNA nanoparticles exhibited excellent uniformity and stability.
• Nanoparticles efficiently entered cells through cellular endocytic pathways.
• The siRNA nanoparticles demonstrated superior inhibition of SARS-CoV-2 replication compared to free siRNA.

Conclusions:

• Self-assembled siRNA nanoparticles targeting conserved SARS-CoV-2 regions are highly effective antiviral candidates.
• This approach shows significant potential for treating current and future SARS-CoV-2 variants.
• The findings support the advancement of siRNA nanoparticle technology for infectious disease treatment.